A Study to Evaluate the Relative Bioavailability and Food Effect of a New Tablet Formulation and Strength of Suzetrigine
Clinical trial NCT06336096 · COMPLETED
Trial details
- NCT number
- NCT06336096
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-28
- Primary completion
- 2024-06-19
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.